Literature DB >> 338926

A comparison of alternate metabolic strategies for the utilization of D-arabinose.

E J St Martin, R P Mortlock.   

Abstract

Mutants of Klebsiella aerogenes W70 that metabolize the uncommon pentose D-arabinose were isolated. These mutants were found to be either constitutive or indicible by D-arabinose for the synthesis of enzymes in the L-fucose pathway. Such mutants could then utilize L-fucose isomerase to convert the structurally similar D-arabinose molecule to D-ribulose. D-Ribulose is an intermediate and the inducer of an existing ribitol pathway and could thus be metabolized. In those D-arabinose-positive mutants where the ribitol pathway was blocked by mutation, D-ribulose could alternatively be metabolized by using the remaining L-fucose pathway enzymes. When the two D-arabinose catabolic routes were compared, catabolism of D-arabinose via the ribitol pathway was found to be more efficient. Catabolism of D-arabinose using the L-fucose pathway permitted D-ribulose to escape into the media and produced an unmetabolizable end product, L-glycolic acid. A comparison of growth using constitutive versus inducible control of the borrowed L-fucose isomerase did not reveal an advantage for one control type over the other. Several differences were observed, however, when we determined the degree to which these control mutations perturbed the normal functioning of the L-fucose and associated pathways. Growth of the constitutive mutant was impaired with L-fucose as substrate. The inducible-control mutant had altered growth characteristics on ribitol and L-rhamnose.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 338926     DOI: 10.1007/bf01751805

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  7 in total

1.  Rihitol and D-arabitol utilization by Aerobacter aerogenes.

Authors:  W A WOOD; M J McDONOUGH; L B JACOBS
Journal:  J Biol Chem       Date:  1961-08       Impact factor: 5.157

2.  A new spectrophotometric method for the detection and determination of keto sugars and trioses.

Authors:  Z DISCHE; E BORENFREUND
Journal:  J Biol Chem       Date:  1951-10       Impact factor: 5.157

3.  D-phosphoarabinoisomerase and D-ribulokinase in Escherichia coli.

Authors:  R Lim; S S Cohen
Journal:  J Biol Chem       Date:  1966-10-10       Impact factor: 5.157

4.  Metabolism of D-arabinose: origin of a D-ribulokinase activity in Escherichia coli.

Authors:  D J LeBlanc; R P Mortlock
Journal:  J Bacteriol       Date:  1971-04       Impact factor: 3.490

5.  Close genetic linkage of the determinants of the ribitol and D-arabitol catabolic pathways in Klebsiella aerogenes.

Authors:  W T Charnetzky; R P Mortlock
Journal:  J Bacteriol       Date:  1974-07       Impact factor: 3.490

6.  Ribitol catabolic pathway in Klebsiella aerogenes.

Authors:  W T Charnetzky; R P Mortlock
Journal:  J Bacteriol       Date:  1974-07       Impact factor: 3.490

7.  Growth of Aerobacter aerogenes on D-arabinose: origin of the enzyme activities.

Authors:  E J Oliver; R P Mortlock
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

  7 in total
  4 in total

1.  Genetic aspects of toxic chemical degradation.

Authors:  J J Kilbane
Journal:  Microb Ecol       Date:  1986-03       Impact factor: 4.552

2.  On the evolution of new metabolic functions in diploid organisms.

Authors:  B G Hall
Journal:  Genetics       Date:  1980-12       Impact factor: 4.562

3.  D-arabinose metabolism in Escherichia coli B: induction and cotransductional mapping of the L-fucose-D-arabinose pathway enzymes.

Authors:  E A Elsinghorst; R P Mortlock
Journal:  J Bacteriol       Date:  1988-12       Impact factor: 3.490

4.  Enzyme promiscuity shapes adaptation to novel growth substrates.

Authors:  Gabriela I Guzmán; Troy E Sandberg; Ryan A LaCroix; Ákos Nyerges; Henrietta Papp; Markus de Raad; Zachary A King; Ying Hefner; Trent R Northen; Richard A Notebaart; Csaba Pál; Bernhard O Palsson; Balázs Papp; Adam M Feist
Journal:  Mol Syst Biol       Date:  2019-04-08       Impact factor: 11.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.